CNBC reported that US House Speaker Nancy Pelosi will not bring her proposed drug-pricing legislation to the floor for a vote this month as previously thought, according to a senior Democratic aide.
The aide said Pelosi's office is awaiting a final review from the Congressional Budget Office (CBO), which is now expected to take two more weeks.
The House was expected to vote on the bill in late October, but it was postponed to this month after the CBO informed Pelosi's office that its timeline had slipped.
Lawmakers made few changes to the bill when it was passed through three committees along partisan lines last month, CNBC said.
Republicans have cited the preliminary CBO report, released earlier that month, that projected the plan would lead to a reduction of eight to 15 new drugs coming to the market over 10 years.
However, the analysis also showed it would save Medicare $345 billion over the decade, mostly due to a provision that would allow the US Department of Health and Human Services to negotiate lower prices on the costliest drugs each year.
To read more NewsPoints articles, click here.